A microbiome company offering probiotics for heart diseases, diabetes, obesity and other diseases
Micropharma Limited discovers and develops bacteria as biotherapeutics for metabolic diseases. The Company uses its proprietary discovery and development platform ProSelect to screen and select bacteria capable of expressing phenotypic traits that can effectively target metabolic pathways recognized as having therapeutic potential.